INSIGHTS ON DRUG DEVELOPMENT
-
Non Animal Origin Squalene For High-Risk Applications
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Formulation Development For Therapeutic Oligonucleotides
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
-
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease
Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques
Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.
-
Quantification Of Exenatide Using Xevo TQD7/29/2025
Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.
-
Inside Bioprocessing: Microbial Media11/4/2025
Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.
-
AI Based Screening And Selection Of Co-Formers For Co-Crystallization11/4/2025
Explore how AI and quantum chemistry are accelerating co-crystal screening and solving solubility challenges in drug development, as well as key technical considerations for identifying optimal co-formers.
-
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions11/20/2025
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
-
Managing Endotoxins - Detect, Prevent, Remove9/8/2025
Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.
DRUG DEVELOPMENT SOLUTIONS
-
The SpectraMax® Mini Multi-Mode Microplate Reader
Perform your favorite applications including ELISA, DNA and protein quantitation, cell viability, gene expression with a user-friendly reader.
-
We have developed an innovative portfolio of affinity chromatography resins to support you in the downstream process of next-generation antibody therapeutics.
-
Leica S9 I Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
Discover an advanced system that is a versatile instrument for absorbance, fluorescence, and luminescence measurements with modular upgrades that enable western blot analysis, imaging, and fast kinetics.